Adverse drug events in hospitalized cardiac patients.
暂无分享,去创建一个
Samuel Z Goldhaber | Lina Matta | Karen Fiumara | S. Goldhaber | S. Baroletti | Lina Matta | K. Fiumara | J. Fanikos | J. Cina | Jennifer L Cina | John Fanikos | Steven Baroletti | Steven A. Baroletti
[1] Impact of smart infusion technology on administration of anticoagulants (unfractionated Heparin, Argatroban, Lepirudin, and Bivalirudin). , 2007, The American journal of cardiology.
[2] Elisabeth Burdick,et al. Recovery from medical errors: the critical care nursing safety net. , 2006, Joint Commission journal on quality and patient safety.
[3] Marvin C. Alkin,et al. What Have We Learned? , 2019, Stumbling Blocks Against Unification.
[4] R. Califf,et al. Relationship of incorrect dosing of fibrinolytic therapy and clinical outcomes. , 2005, JAMA.
[5] E. Etchells,et al. Unintended medication discrepancies at the time of hospital admission. , 2005, Archives of internal medicine.
[6] C. Clancy,et al. Improving patient safety--five years after the IOM report. , 2004, The New England journal of medicine.
[7] J. Rothschild,et al. Effect of reducing interns' weekly work hours on sleep and attentional failures. , 2004, The New England journal of medicine.
[8] D. Bates,et al. Effect of reducing interns' work hours on serious medical errors in intensive care units. , 2004, The New England journal of medicine.
[9] J. Simpson,et al. Reducing medication errors in the neonatal intensive care unit , 2004, Archives of Disease in Childhood - Fetal and Neonatal Edition.
[10] S. Goldhaber,et al. Medication errors associated with anticoagulant therapy in the hospital. , 2004, The American journal of cardiology.
[11] Melissa M. Honour,et al. Overcoming barriers to adopting and implementing computerized physician order entry systems in U.S. hospitals. , 2004, Health affairs.
[12] S. Schroeder,et al. How Many Hours Is Enough? An Old Profession Meets a New Generation , 2004, Annals of Internal Medicine.
[13] P. Barach,et al. Clarifying Adverse Drug Events: A Clinician's Guide to Terminology, Documentation, and Reporting , 2004, Annals of Internal Medicine.
[14] S. Gavi,et al. Adverse events due to discontinuations in drug use and dose changes in patients transferred between acute and long-term care facilities. , 2004, Archives of internal medicine.
[15] J. Jollis,et al. Medication errors in hospitalized cardiovascular patients. , 2003, Archives of internal medicine.
[16] R. Kerber,et al. Medication Errors in Acute Cardiac Care: An American Heart Association Scientific Statement From the Council on Clinical Cardiology Subcommittee on Acute Cardiac Care, Council on Cardiopulmonary and Critical Care, Council on Cardiovascular Nursing, and Council on Stroke , 2002, Circulation.
[17] J. A. N. Eedleman,et al. Nurse-Staffing Levels and the Quality of Care in Hospitals , 2002 .
[18] D. Redelmeier,et al. Mortality among patients admitted to hospitals on weekends as compared with weekdays. , 2001, The New England journal of medicine.
[19] D. Bates,et al. Medication errors and adverse drug events in pediatric inpatients. , 2001, JAMA.
[20] P. Chyka,et al. How many deaths occur annually from adverse drug reactions in the United States? , 2000, The American journal of medicine.
[21] S. Grant. Viewpoint: Who's to Blame for Tragic Error? , 1999 .
[22] S. Grant. Who's to blame for tragic error? , 1999, The American journal of nursing.
[23] D. Bates,et al. The Costs of Adverse Drug Events in Hospitalized Patients , 1997 .
[24] D. Classen,et al. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. , 1997, JAMA.
[25] N. Dickey,et al. Systems analysis of adverse drug events. , 1996, JAMA.
[26] J. A. Johnson,et al. Drug-Related Morbidity and Mortality: A Cost-of-Illness Model , 1995 .
[27] N. Laird,et al. Incidence of adverse drug events and potential adverse drug events , 1995 .
[28] S. Brink. 1995 best hospitals. Tragedy at Dana-Farber. , 1995, U.S. news & world report.
[29] N. Laird,et al. Incidence of Adverse Drug Events and Potential Adverse Drug Events: Implications for Prevention , 1995 .
[30] D. Bates,et al. Systems analysis of adverse drug events. ADE Prevention Study Group. , 1995, JAMA.